Mesoblast Limited (MESO): Price and Financial Metrics
MESO Price/Volume Stats
| Current price | $11.61 | 52-week high | $22.00 |
| Prev. close | $11.46 | 52-week low | $5.78 |
| Day low | $11.46 | Volume | 179,200 |
| Day high | $11.80 | Avg. volume | 297,440 |
| 50-day MA | $11.28 | Dividend yield | N/A |
| 200-day MA | $11.94 | Market Cap | 1.48B |
MESO Stock Price Chart Interactive Chart >
Mesoblast Limited (MESO) Company Bio
Mesoblast Ltd. has established a diverse portfolio of product candidates based on its proprietary allogeneic, off-the-shelf mesenchymal lineage cell-based technology, with multiple active Phase 3 clinical programs. Mesoblast's lead product candidates target major diseases with significant unmet medical needs despite existing therapies. These include chronic heart failure, chronic low back pain due to degenerative disc disease, and immune-mediated conditions such as acute graft versus host disease and biologic refractory rheumatoid arthritis. The company is based in Melbourne, Australia.
MESO Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
MESO Price Returns
| 1-mo | 5.07% |
| 3-mo | -13.81% |
| 6-mo | 4.59% |
| 1-year | 70.23% |
| 3-year | 89.71% |
| 5-year | -54.75% |
| YTD | -41.36% |
| 2024 | 800.00% |
| 2023 | -62.20% |
| 2022 | -39.38% |
| 2021 | -43.46% |
| 2020 | 15.20% |